Skip to main content
Thu, Mar 19, 2026
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
ScienceGermany1 sourcesNeutral

R1’s $77.5M series A to fund CKD trial of oral phosphate inhibitor

Newco R1 Therapeutics Inc. has launched with an oversubscribed $77.5 million series A, providing the means to take AP-306, a potentially first-in-class hyperphosphatemia therapy through phase IIb development in patients with chronic kidney disease.

NM
nuala moran
via Bioworld
ShareRead original

Read the full article at Bioworld →

R1’s $77.5M series A to fund CKD trial of oral phosphate inhibitor

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Bioworld
Bioworld
NewsDataDE

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
My 'panic attacks' turned out to be much more serious - I needed brain surgery
Next
Five Likely Busts From 2026 NFL Free Agency

Related Articles

【AICC Original Article】Appreciating the Grand Canal through Rows of Willows: A Time-honored Cultural Pulse ReinvigoratedScience
【AICC Original Article】Appreciating the Grand Canal through Rows of Willows: A Time-honored Cultural Pulse Reinvigorated
Unknown-5h ago-1 sources
One Dead, Three Trapped After Kericho Building CollapsesScience
One Dead, Three Trapped After Kericho Building Collapses
Unknown-9h ago-1 sources
How AI-generated videos are distorting your child’s YouTube feedScience
How AI-generated videos are distorting your child’s YouTube feed
Merinvarghese-10h ago-1 sources